|
|
Volumn 7, Issue 4, 1996, Pages 335-337
|
|
Gemcitabine for pancreatic cancer: How hard to look for clinical benefit? An American perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
GEMCITABINE;
OCTREOTIDE;
TAMOXIFEN;
ALOPECIA;
BLOOD TOXICITY;
CANCER PAIN;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HUMAN;
PANCREAS CANCER;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
TREATMENT OUTCOME;
VOMITING;
|
|
EID: 0030039146
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.annonc.a010597 Document Type: Editorial |
|
Times cited : (17)
|
|
References (0)
|
